Zurich Cantonal Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $157K | Hold |
7,783
| – | – | ﹤0.01% | 2353 |
|
|
2026
Q1 | $152K | Buy |
+7,783
| New | +$190K | ﹤0.01% | 2305 |
|
|
2025
Q4 | – | Sell |
-7,504
| Closed | -$193K | – | 2590 |
|
|
2025
Q3 | $200K | Hold |
7,504
| – | – | ﹤0.01% | 2195 |
|
|
2025
Q2 | $172K | Hold |
7,504
| – | – | ﹤0.01% | 2203 |
|
|
2025
Q1 | $218K | Hold |
7,504
| – | – | ﹤0.01% | 2061 |
|
|
2024
Q4 | $279K | Buy |
7,504
+1,260
| +20% | +$57.6K | ﹤0.01% | 1986 |
|
|
2024
Q3 | $303K | Hold |
6,244
| – | – | ﹤0.01% | 1874 |
|
|
2024
Q2 | $250K | Sell |
6,244
-2,623
| -30% | -$109K | ﹤0.01% | 1928 |
|
|
2024
Q1 | $389K | Sell |
8,867
-1,925
| -18% | -$99.4K | ﹤0.01% | 1637 |
|
|
2023
Q4 | $667K | Buy |
10,792
+1,356
| +14% | +$71.2K | ﹤0.01% | 1319 |
|
|
2023
Q3 | $434K | Buy |
9,436
+1,582
| +20% | +$86.3K | ﹤0.01% | 1485 |
|
|
2023
Q2 | $451K | Buy |
7,854
+1,051
| +15% | +$46.6K | ﹤0.01% | 1415 |
|
|
2023
Q1 | $255K | Sell |
6,803
-1,028
| -13% | -$33.7K | ﹤0.01% | 1723 |
|
|
2022
Q4 | $219K | Buy |
7,831
+1,369
| +21% | +$39.8K | ﹤0.01% | 1765 |
|
|
2022
Q3 | $182K | Hold |
6,462
| – | – | ﹤0.01% | 1812 |
|
|
2022
Q2 | $225K | Buy |
6,462
+1,061
| +20% | +$37.9K | ﹤0.01% | 1717 |
|
|
2022
Q1 | $194K | Sell |
5,401
-1,309
| -20% | -$37.1K | ﹤0.01% | 1903 |
|
|
2021
Q4 | $156K | Buy |
6,710
+3,161
| +89% | +$64.6K | ﹤0.01% | 2243 |
|
|
2021
Q3 | $67K | Hold |
3,549
| – | – | ﹤0.01% | 2522 |
|
|
2021
Q2 | $72K | Sell |
3,549
-1,791
| -34% | -$33.7K | ﹤0.01% | 2350 |
|
|
2021
Q1 | $98K | Hold |
5,340
| – | – | ﹤0.01% | 2162 |
|
|
2020
Q4 | $107K | Hold |
5,340
| – | – | ﹤0.01% | 2180 |
|
|
2020
Q3 | $100K | Hold |
5,340
| – | – | ﹤0.01% | 1990 |
|
|
2020
Q2 | $120K | Buy |
5,340
+2,929
| +121% | +$53.6K | ﹤0.01% | 1846 |
|
|
2020
Q1 | $36K | Hold |
2,411
| – | – | ﹤0.01% | 2085 |
|
|
2019
Q4 | $47K | Hold |
2,411
| – | – | ﹤0.01% | 2175 |
|
|
2019
Q3 | $48K | Hold |
2,411
| – | – | ﹤0.01% | 2068 |
|
|
2019
Q2 | $51K | Hold |
2,411
| – | – | ﹤0.01% | 2050 |
|
|
2019
Q1 | $49K | Sell |
2,411
-777
| -24% | -$17.4K | ﹤0.01% | 2015 |
|
|
2018
Q4 | $63K | Hold |
3,188
| – | – | ﹤0.01% | 1888 |
|
|
2018
Q3 | $61K | Hold |
3,188
| – | – | ﹤0.01% | 2028 |
|
|
2018
Q2 | $49K | Hold |
3,188
| – | – | ﹤0.01% | 2139 |
|
|
2018
Q1 | $60K | Hold |
3,188
| – | – | ﹤0.01% | 1937 |
|
|
2017
Q4 | $61K | Buy |
3,188
+1,105
| +53% | +$20.6K | ﹤0.01% | 1901 |
|
|
2017
Q3 | $37K | Hold |
2,083
| – | – | ﹤0.01% | 1987 |
|
|
2017
Q2 | $37K | Hold |
2,083
| – | – | ﹤0.01% | 1925 |
|
|
2017
Q1 | $30K | Hold |
2,083
| – | – | ﹤0.01% | 2106 |
|
|
2016
Q4 | $38K | Hold |
2,083
| – | – | ﹤0.01% | 1877 |
|
|
2016
Q3 | $40K | Buy |
2,083
+335
| +19% | +$6.08K | ﹤0.01% | 1783 |
|
|
2016
Q2 | $28K | Hold |
1,748
| – | – | ﹤0.01% | 1838 |
|
|
2016
Q1 | $21K | Hold |
1,748
| – | – | ﹤0.01% | 2003 |
|
|
2015
Q4 | $25K | Buy |
1,748
+1,274
| +269% | +$16.8K | ﹤0.01% | 1880 |
|
|
2015
Q3 | $6K | Buy |
+474
| New | +$7.11K | ﹤0.01% | 2345 |
|
Other funds holding AMPH
Zurich Cantonal Bank's AMPH Position: Q2 2026 in Review
Zurich Cantonal Bank held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 7,783 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.
Zurich Cantonal Bank first reported a position in AMPH in Q3 2015 and has held it in 43 quarters since. The position peaked at $667K in Q4 2023. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Zurich Cantonal Bank held 7,783 shares of Amphastar Pharmaceuticals worth $157K as of Q2 2026.
- Zurich Cantonal Bank left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2353 holding.
- Zurich Cantonal Bank first reported a position in Amphastar Pharmaceuticals in Q3 2015 and has held it in 43 quarters since.
- Zurich Cantonal Bank's Amphastar Pharmaceuticals position peaked at $667K in Q4 2023.
- 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.